International Patent: CANCER IMMUNOTHERAPY COMPOSITION COMPRISING BENZOYLINDOLIZINE-BASED COMPOUND AS ACTIVE INGREDIENT

GENEVA, Oct. 30 -- KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY filed a patent application (KR2026/005115) for “CANCER IMMUNOTHERAPY COMPOSITION COMPRISING BENZOYLINDOLIZINE-BASED COMPOUND AS ACTIVE INGREDIENT”. With publication no. WO/2026/225810, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/437

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....